FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2797249179> ?p ?o ?g. }

• W2797249179 endingPage "1104" @default.
• W2797249179 startingPage "1096" @default.
• W2797249179 abstract "To assess the pharmacokinetic and pharmacodynamic profile of a single dose of empagliflozin in young people with Type 2 diabetes to identify the appropriate doses for further paediatric development.We conducted a single-dose, open-label, randomized, parallel-group study with empagliflozin 5 mg, 10 mg and 25 mg in young people with Type 2 diabetes aged 10-17 years.Of 39 participants screened, 27 were randomized and completed the study; their mean (± sd) age was 14.1±2.0 years and body weight was 96.7±23.5 kg. Compared with similar studies in adults with Type 2 diabetes, the maximum observed plasma concentrations were slightly lower with the 10-mg and 25-mg doses, and the area under the plasma concentration-time curve was slightly lower with the 10-mg but slightly higher with the 25-mg dose. The adjusted mean increases in urinary glucose excretion were 53 g/24 h (95% CI 32,74), 73 g/24 h (95% CI 52,94) and 87 g/24 h (95% CI 68,107), and the adjusted mean decreases in fasting plasma glucose were 0.9 mmol/l (95% CI -1.6,-0.1), 0.9 mmol/l (95% CI -1.7,-0.2) and 1.1 mmol/l (95% CI -1.8,-0.5) for the 5- 10- and 25-mg doses, respectively. There were no serious adverse events and one investigator-reported drug-related event (dehydration).After a single oral dose of empagliflozin, adults and young people with Type 2 diabetes had similar exposure-response relationships after adjusting for significant covariates. These data support testing 10-mg and/or 25-mg doses of empagliflozin in an upcoming paediatric phase III Type 2 diabetes trial. (ClinicalTrials.gov registration no.: NCT02121483)." @default.
• W2797249179 created "2018-04-24" @default.
• W2797249179 creator A5002265183 @default.
• W2797249179 creator A5008074747 @default.
• W2797249179 creator A5009411810 @default.
• W2797249179 creator A5028129860 @default.
• W2797249179 creator A5039437817 @default.
• W2797249179 creator A5058478381 @default.
• W2797249179 creator A5060236174 @default.
• W2797249179 creator A5068220116 @default.
• W2797249179 creator A5069785394 @default.
• W2797249179 creator A5074266705 @default.
• W2797249179 date "2018-05-06" @default.
• W2797249179 modified "2023-10-03" @default.
• W2797249179 title "Pharmacokinetic and pharmacodynamic profile of the sodium‐glucose co‐transporter‐2 inhibitor empagliflozin in young people with Type 2 diabetes: a randomized trial" @default.
• W2797249179 cites W1538553036 @default.
• W2797249179 cites W1847388060 @default.
• W2797249179 cites W2034098851 @default.
• W2797249179 cites W2051243940 @default.
• W2797249179 cites W2054606580 @default.
• W2797249179 cites W2056520796 @default.
• W2797249179 cites W2069283448 @default.
• W2797249179 cites W2090979363 @default.
• W2797249179 cites W2101344933 @default.
• W2797249179 cites W2101374656 @default.
• W2797249179 cites W2118243882 @default.
• W2797249179 cites W2128219379 @default.
• W2797249179 cites W2137069992 @default.
• W2797249179 cites W2138173919 @default.
• W2797249179 cites W2146264128 @default.
• W2797249179 cites W2152413054 @default.
• W2797249179 cites W2153336680 @default.
• W2797249179 cites W2424539745 @default.
• W2797249179 cites W2606106417 @default.
• W2797249179 cites W2797249179 @default.
• W2797249179 doi "https://doi.org/10.1111/dme.13629" @default.
• W2797249179 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6099360" @default.
• W2797249179 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29655290" @default.
• W2797249179 hasPublicationYear "2018" @default.
• W2797249179 type Work @default.
• W2797249179 sameAs 2797249179 @default.
• W2797249179 citedByCount "26" @default.
• W2797249179 countsByYear W27972491792019 @default.
• W2797249179 countsByYear W27972491792020 @default.
• W2797249179 countsByYear W27972491792021 @default.
• W2797249179 countsByYear W27972491792022 @default.
• W2797249179 countsByYear W27972491792023 @default.
• W2797249179 crossrefType "journal-article" @default.
• W2797249179 hasAuthorship W2797249179A5002265183 @default.
• W2797249179 hasAuthorship W2797249179A5008074747 @default.
• W2797249179 hasAuthorship W2797249179A5009411810 @default.
• W2797249179 hasAuthorship W2797249179A5028129860 @default.
• W2797249179 hasAuthorship W2797249179A5039437817 @default.
• W2797249179 hasAuthorship W2797249179A5058478381 @default.
• W2797249179 hasAuthorship W2797249179A5060236174 @default.
• W2797249179 hasAuthorship W2797249179A5068220116 @default.
• W2797249179 hasAuthorship W2797249179A5069785394 @default.
• W2797249179 hasAuthorship W2797249179A5074266705 @default.
• W2797249179 hasBestOaLocation W27972491791 @default.
• W2797249179 hasConcept C111113717 @default.
• W2797249179 hasConcept C112705442 @default.
• W2797249179 hasConcept C126322002 @default.
• W2797249179 hasConcept C134018914 @default.
• W2797249179 hasConcept C168563851 @default.
• W2797249179 hasConcept C197934379 @default.
• W2797249179 hasConcept C2775887513 @default.
• W2797249179 hasConcept C2777180221 @default.
• W2797249179 hasConcept C555293320 @default.
• W2797249179 hasConcept C71924100 @default.
• W2797249179 hasConcept C90924648 @default.
• W2797249179 hasConcept C98274493 @default.
• W2797249179 hasConceptScore W2797249179C111113717 @default.
• W2797249179 hasConceptScore W2797249179C112705442 @default.
• W2797249179 hasConceptScore W2797249179C126322002 @default.
• W2797249179 hasConceptScore W2797249179C134018914 @default.
• W2797249179 hasConceptScore W2797249179C168563851 @default.
• W2797249179 hasConceptScore W2797249179C197934379 @default.
• W2797249179 hasConceptScore W2797249179C2775887513 @default.
• W2797249179 hasConceptScore W2797249179C2777180221 @default.
• W2797249179 hasConceptScore W2797249179C555293320 @default.
• W2797249179 hasConceptScore W2797249179C71924100 @default.
• W2797249179 hasConceptScore W2797249179C90924648 @default.
• W2797249179 hasConceptScore W2797249179C98274493 @default.
• W2797249179 hasFunder F4320306257 @default.
• W2797249179 hasIssue "8" @default.
• W2797249179 hasLocation W27972491791 @default.
• W2797249179 hasLocation W27972491792 @default.
• W2797249179 hasLocation W27972491793 @default.
• W2797249179 hasLocation W27972491794 @default.
• W2797249179 hasOpenAccess W2797249179 @default.
• W2797249179 hasPrimaryLocation W27972491791 @default.
• W2797249179 hasRelatedWork W1758514097 @default.
• W2797249179 hasRelatedWork W1997101420 @default.
• W2797249179 hasRelatedWork W2002058825 @default.
• W2797249179 hasRelatedWork W2010116591 @default.
• W2797249179 hasRelatedWork W2090099591 @default.
• W2797249179 hasRelatedWork W2108417615 @default.
• W2797249179 hasRelatedWork W2227061539 @default.

• next